-
Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial
W.H. Zwart, Sofieke J. D. Temmink, Geke A.P. Hospers, Corrie A.M. Marijnen, Hein Putter, Irıs D. Nagtegaal, +9 more
43citations -
Active surveillance versus treatment in low-risk DCIS: Women’s preferences in the LORD-trial2023 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Renée Schmitz, Ellen G. Engelhardt, Miranda A. Gerritsma, Carine Sondermeijer, Ellen Verschuur, Julia Houtzager, +7 more
42citations -
Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours2022 European Journal of Cancer article Medicine Musculoskeletal synovial abnormalities and treatments Open access
Geert Spierenburg, Peter Grimison, Christine Chevreau, Silvia Stacchiotti, Sophie Piperno‐Neumann, Axel Le Cesne, +11 more
36citations -
Adjuvant treatment for melanoma in clinical practice – Trial versus reality2021 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Melissa Melanie de Meza, Rawa Kamaran Ismail, Daan Jan Willem Rauwerdink, Olivier J. van Not, Jesper van Breeschoten, Willeke A.M. Blokx, +22 more
36citations -
Neo-adjuvant immunotherapy emerges as best medical practice, and will be the new standard of care for macroscopic stage III melanoma2023 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Alexander C. J. van Akkooi, Christian U. Blank, Alexander M.M. Eggermont
35citations -
Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group2024 European Journal of Cancer article Medicine Cutaneous lymphoproliferative disorders research Open access
Khaled Elsayad, Emmanuella Guenova, Chalid Assaf, Jan Peter Nicolay, Franz Trautinger, Rudolf Stadler, +27 more
33citations -
Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo2024 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Irene L. M. Reijers, Alexander Maxwell Menzies, Marta López‐Yurda, Judith M. Versluis, Elisa A. Rozeman, Robyn P.M. Saw, +18 more
33citations -
Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy
Liesbeth M. Hondelink, Sophie M. Ernst, Peggy N. Atmodimedjo, Danielle B. Cohen, Janina L Wolf, Anne‐Marie C. Dingemans, +2 more
33citations -
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy2022 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Marjanka K. Schmidt, Anne Brédart, David Cameron, Jana de Boniface, Douglas F. Easton, Birgitte Vrou Offersen, +7 more
32citations -
Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour2021 European Journal of Cancer article Medicine Gastrointestinal Tumor Research and Treatment Open access
Suzanne George, Ping Chi, Michael Charles Heinrich, Margaret von Mehren, Robin L. Jones, Kristen N. Ganjoo, +11 more
31citations -
Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registry2020 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Michiel C.T. van Zeijl, Liesbeth C. de Wreede, Alfons J.M. van den Eertwegh, Michel W.J.M. Wouters, Anouk Jochems, Maartje Gisele Schouwenburg, +14 more
31citations -
Health-related quality of life in Dutch adult survivors of childhood cancer: A nation-wide cohort study2021 European Journal of Cancer article Medicine Childhood Cancer Survivors' Quality of Life Open access
Loes M. E. van Erp, Heleen Maurice‐Stam, Leontien C.M. Kremer, Wim J. E. Tissing, Helena J. H. van der Pal, Andrica C. H. de Vries, +12 more
31citations -
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group ‘Molecular Diagnostics and Therapy’2020 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics
Christoph Benedikt Westphalen, Carsten Bokemeyer, Reinhard Büttner, Stefan Fröhling, Verena I. Gaidzik, Hanno Glimm, +57 more
30citations -
Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country: Data from the Netherlands in the period 2009–20162020 European Journal of Cancer article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Margot T.M. Reinders, Suzanne van Meer, Mark Christiaan Burgmans, Koert Pieter de Jong, Heinz‐Josef Klümpen, Robert Auke de Man, +6 more
30citations -
Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma2021 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Judith M. Versluis, Irene L. M. Reijers, Elisa A. Rozeman, Alexander Maxwell Menzies, Alexander C. J. van Akkooi, Michel W.J.M. Wouters, +7 more
29citations -
In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations
Francesca Piaggio, Michela Croce, Francesco Reggiani, Paola Monti, Cinzia Bernardi, Marianna Ambrosio, +16 more
29citations